GB0302167D0 - T cell phenotype - Google Patents
T cell phenotypeInfo
- Publication number
- GB0302167D0 GB0302167D0 GBGB0302167.2A GB0302167A GB0302167D0 GB 0302167 D0 GB0302167 D0 GB 0302167D0 GB 0302167 A GB0302167 A GB 0302167A GB 0302167 D0 GB0302167 D0 GB 0302167D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cell phenotype
- phenotype
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/51—B7 molecules, e.g. CD80, CD86, CD28 (ligand), CD152 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/52—CD40, CD40-ligand (CD154)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0302167.2A GB0302167D0 (en) | 2003-01-30 | 2003-01-30 | T cell phenotype |
EP04706580A EP1590449A2 (en) | 2003-01-30 | 2004-01-30 | Icos+ suppresser t cells |
PCT/BE2004/000017 WO2004067697A2 (en) | 2003-01-30 | 2004-01-30 | Icos+ suppresser t cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0302167.2A GB0302167D0 (en) | 2003-01-30 | 2003-01-30 | T cell phenotype |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0302167D0 true GB0302167D0 (en) | 2003-03-05 |
Family
ID=9952134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0302167.2A Ceased GB0302167D0 (en) | 2003-01-30 | 2003-01-30 | T cell phenotype |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1590449A2 (en) |
GB (1) | GB0302167D0 (en) |
WO (1) | WO2004067697A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113341161A (en) * | 2021-06-10 | 2021-09-03 | 苏州大学附属第一医院 | Application of ICOS/ICOSL in diagnosis and treatment of allergic skin diseases |
CN113981031A (en) * | 2021-11-01 | 2022-01-28 | 山西中医药大学 | Novel T cell function detection method |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011524741A (en) | 2008-05-27 | 2011-09-08 | 協和発酵キリン株式会社 | Interleukin 10 receptor (IL-10R) antibody and method of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1241249A1 (en) * | 2001-03-12 | 2002-09-18 | Gerold Schuler | CD4+CD25+regulatory T cells from human blood |
DE60210623T2 (en) * | 2001-05-30 | 2007-02-15 | Fondazione Téléthon | EX-VIVO ISOLATED CD25 + CD4 + T CELLS WITH IMMUNOSUPPRESSIVE ACTIVITY AND ITS APPLICATIONS |
-
2003
- 2003-01-30 GB GBGB0302167.2A patent/GB0302167D0/en not_active Ceased
-
2004
- 2004-01-30 EP EP04706580A patent/EP1590449A2/en not_active Withdrawn
- 2004-01-30 WO PCT/BE2004/000017 patent/WO2004067697A2/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113341161A (en) * | 2021-06-10 | 2021-09-03 | 苏州大学附属第一医院 | Application of ICOS/ICOSL in diagnosis and treatment of allergic skin diseases |
CN113981031A (en) * | 2021-11-01 | 2022-01-28 | 山西中医药大学 | Novel T cell function detection method |
Also Published As
Publication number | Publication date |
---|---|
WO2004067697B1 (en) | 2004-11-18 |
EP1590449A2 (en) | 2005-11-02 |
WO2004067697A3 (en) | 2004-09-16 |
WO2004067697A2 (en) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1897548T1 (en) | T cell regulation | |
GB0329449D0 (en) | Stem cells | |
EP1989528A4 (en) | Cell tray | |
GB2404665B (en) | Cell culture | |
HK1097885A1 (en) | Electrochemical cell | |
AU2003290432A8 (en) | T cell activating gene | |
GB0316629D0 (en) | Transgenic cell | |
ZA200506732B (en) | Cell culture | |
HK1096487A1 (en) | Photovoltaic cell | |
GB0206357D0 (en) | Cells | |
EP1640453A4 (en) | Digital cell | |
AU157289S (en) | Battery | |
GB0407620D0 (en) | Cell lines | |
GB0302167D0 (en) | T cell phenotype | |
GB0328943D0 (en) | Differentiated cells | |
EP1690933A4 (en) | hERG CHANNEL-EXPRESSING CELL | |
GB0320506D0 (en) | Cell scheduling | |
IL158173A0 (en) | Nanopatch-containing cells | |
GB2394477B (en) | Cell culture | |
IL162558A (en) | Cooled photosensitive cell | |
PL376397A1 (en) | Transplantable cell | |
GB0301834D0 (en) | Methods employing cells | |
GB0226482D0 (en) | Elecrochemical cell | |
GB0314561D0 (en) | Cell culture | |
GB0325248D0 (en) | Transfected cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |